Ljubic Nemanja, Ueberberg Bianca, Grunze Heinz, Assion Hans-Jörg
Bereich Forschung & Wissenschaft, LWL-Klinik, Marsbruchstr. 179, 44287 Dortmund, Germany (Ljubic, Ueberberg, Assion); Psychiatrie Schwäbisch Hall, Ringstraße. 1, 74523 Schwäbisch Hall, Germany (Grunze); Paracelsus Medical University, Ernst-Nathan Straße 1, 90419 Nuremberg, Germany (Grunze).
Focus (Am Psychiatr Publ). 2023 Oct;21(4):434-443. doi: 10.1176/appi.focus.23021024. Epub 2023 Oct 15.
Old age bipolar disorder has been an orphan of psychiatric research for a long time despite the fact that bipolar disorder (BD)-I and II together may affect 0.5-1.0% of the elderly. It is also unclear whether aetiology, course of illness and treatment should differ in patients with a first manifestation in older age and patients suffering from a recurrence of a BD known for decades. This narrative review will summarize the current state of knowledge about the epidemiology, clinical features, and treatment of BD in the elderly.
We conducted a Medline literature search from 1970 to 2021 using MeSH terms "Bipolar Disorder" × "Aged" or "Geriatric" or "Elderly". Search results were complemented by additional literature retrieved from examining cross references and by hand search in text books.
Varying cut-off ages have been applied to differentiate old age from adult age BD. Within old age BD, there is a reasonable agreement of distinct entities, early and late-onset BD. They differ to some extent in clinical symptoms, course of illness, and some co-morbidities. Point prevalence of BD in older adults appears slightly lower than in working-age adults, with polarity of episodes shifting towards depression. Psychopharmacological treatment needs to take into account the special aspects of somatic gerontology and the age-related change of pharmacokinetic and pharmacodynamic characteristics. The evidence for commonly used treatments such as lithium, moodstabilizing antiepileptics, antipsychotics, and antidepressants remains sparse. Preliminary results support a role of ECT as well as psychotherapy and psychosocial interventions in old age BD.
There is an obvious need of further research for all treatment modalities of BD in old age. The focus should be pharmacological and psychosocial approaches, as well as their combination, and the role of physical treatment modalities such as ECT.Appeared originally in .
尽管双相情感障碍(BD)I型和II型合起来可能影响0.5%-1.0%的老年人,但老年双相情感障碍长期以来一直是精神科研究的冷门领域。对于首次发病于老年的患者和患有已确诊数十年的双相情感障碍复发的患者,其病因、病程和治疗是否应有所不同也尚不清楚。本叙述性综述将总结关于老年双相情感障碍的流行病学、临床特征和治疗的当前知识状态。
我们使用医学主题词“双相情感障碍”ד老年人”或“老年病学”或“老年人”,对1970年至2021年的Medline文献进行了检索。通过检查交叉参考文献检索到的其他文献以及教科书的手工检索对搜索结果进行了补充。
不同的年龄界限被用于区分老年双相情感障碍和成年双相情感障碍。在老年双相情感障碍中,对于早发和晚发双相情感障碍这两个不同实体存在合理的共识。它们在临床症状、病程和一些合并症方面存在一定程度的差异。老年双相情感障碍的点患病率似乎略低于工作年龄的成年人,发作极性向抑郁转变。心理药物治疗需要考虑老年躯体医学的特殊方面以及药代动力学和药效学特征的年龄相关变化。锂盐、心境稳定剂抗癫痫药、抗精神病药和抗抑郁药等常用治疗方法的证据仍然稀少。初步结果支持电休克治疗以及心理治疗和社会心理干预在老年双相情感障碍中的作用。
老年双相情感障碍的所有治疗方式显然都需要进一步研究。重点应是药物和社会心理方法及其组合,以及电休克治疗等物理治疗方式的作用。最初发表于 。